\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\\ pelvic\\ exam\\.\ \(0\)\
\-\ patient\\ to\\ undergo\\ endometrial\\ biopsy\\ to\\ remove\\ polyps\\.\ \(0\)\
\-\ transvaginal\\ ultrasound\\ demonstrates\\ an\\ area\\ of\\ focal\\ thickening\\ of\\ the\\ endometrial\\ stripe\\.\\ on\\ subsequent\\ sonohysterography\\,\\ two\\ well\\-defined\\,\\ smooth\\,\\ polypoid\\ lesions\\,\\ isoechoic\\ to\\ the\\ endometrium\\ are\\ seen\\ extending\\ into\\ the\\ endometrial\\ canal\\.\ \(0\)\
\-\ endometrial\\ polyps\ \(2\)\
\-\ endometrial\\ polyp\\(s\\)\ \(0\)\
\-\ submucosal\\ fibroid\\(s\\)\ \(0\)\
\-\ glandular\\ hyperplasia\ \(0\)\
\-\ 41\\ y\\/o\\ female\\ with\\ irregular\\ menstrual\\ bleeding\\.\ \(1\)\
\-\ endometrial\\ polyps\\ are\\ a\\ common\\ cause\\ of\\ dysfunctional\\ uterine\\ bleeding\\ and\\ can\\ be\\ seen\\ in\\ 30\\%\\ of\\ cases\\ of\\ dysfunctional\\ uterine\\ bleeding\\.\\ \\ this\\ patient\\ had\\ two\\ endometrial\\ polyps\\ that\\ were\\ seen\\ on\\ sonohysterography\\.\\ \\ multiple\\ polyps\\ are\\ seen\\ in\\ aproximately\\ 20\\%\\ of\\ cases\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endometrial\\:\\ 0\\.585598596951486\ \(0\)\
\-\ polyps\\:\\ 0\\.44164606886240854\ \(0\)\
\-\ sonohysterography\\:\\ 0\\.25031125158669776\ \(0\)\
\-\ dysfunctional\\:\\ 0\\.22214662362751136\ \(0\)\
\-\ bleeding\\:\\ 0\\.20082098393042572\ \(0\)\
\-\ seen\\:\\ 0\\.15423282332505675\ \(0\)\
\-\ uterine\\:\\ 0\\.15296630931190847\ \(0\)\
\-\ aproximately\\:\\ 0\\.12102521343245487\ \(0\)\
\-\ cases\\:\\ 0\\.110173621744264\ \(0\)\
\-\ glandular\\:\\ 0\\.10525182255595046\ \(0\)\
\-\ endometrium\\:\\ 0\\.10303859505806584\ \(0\)\
\-\ isoechoic\\:\\ 0\\.10204802582733617\ \(0\)\
\-\ transvaginal\\:\\ 0\\.10112141019505647\ \(0\)\
\-\ two\\:\\ 0\\.09727423046909457\ \(0\)\
\-\ polypoid\\:\\ 0\\.09654919192585835\ \(0\)\
\-\ of\\:\\ 0\\.09616567527879263\ \(0\)\
\-\ menstrual\\:\\ 0\\.09471381673782789\ \(0\)\
\-\ stripe\\:\\ 0\\.09415070303028691\ \(0\)\
\-\ are\\:\\ 0\\.0932328194062107\ \(0\)\
\-\ submucosal\\:\\ 0\\.09072770266805315\ \(0\)\
\-\ fibroid\\:\\ 0\\.08988289671075234\ \(0\)\
\-\ remove\\:\\ 0\\.08832921377248171\ \(0\)\
\-\ polyp\\:\\ 0\\.08339349357854486\ \(0\)\
\-\ undergo\\:\\ 0\\.07648315465595423\ \(0\)\
\-\ 41\\:\\ 0\\.07510007506497758\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.07466715103701407\ \(0\)\
\-\ smooth\\:\\ 0\\.06762010270204045\ \(0\)\
\-\ pelvic\\:\\ 0\\.0640215125889071\ \(0\)\
\-\ irregular\\:\\ 0\\.06323098858326902\ \(0\)\
\-\ canal\\:\\ 0\\.06303997611035503\ \(0\)\
\-\ subsequent\\:\\ 0\\.062003098922682985\ \(0\)\
\-\ to\\:\\ 0\\.06142507328060211\ \(0\)\
\-\ biopsy\\:\\ 0\\.057409499325463804\ \(0\)\
\-\ 30\\:\\ 0\\.05587116385964625\ \(0\)\
\-\ cause\\:\\ 0\\.055794590029536434\ \(0\)\
\-\ thickening\\:\\ 0\\.05571842242855259\ \(0\)\
\-\ extending\\:\\ 0\\.055529752708211755\ \(0\)\
\-\ unremarkable\\:\\ 0\\.05490621026303107\ \(0\)\
\-\ patient\\:\\ 0\\.053276399216058375\ \(0\)\
\-\ area\\:\\ 0\\.05305648468988518\ \(0\)\
\-\ 20\\:\\ 0\\.05283728105626569\ \(0\)\
\-\ ultrasound\\:\\ 0\\.05051789736969096\ \(0\)\
\-\ on\\:\\ 0\\.049470859303194704\ \(0\)\
\-\ the\\:\\ 0\\.049026496557902685\ \(0\)\
\-\ focal\\:\\ 0\\.048989321590365634\ \(0\)\
\-\ lesions\\:\\ 0\\.04703652473941016\ \(0\)\
\-\ common\\:\\ 0\\.04644710125685728\ \(0\)\
\-\ into\\:\\ 0\\.043537024121431664\ \(0\)\
\-\ can\\:\\ 0\\.04297891435542874\ \(0\)\
\-\ were\\:\\ 0\\.04221746556316422\ \(0\)\
\-\ exam\\:\\ 0\\.041228874093869286\ \(0\)\
\-\ demonstrates\\:\\ 0\\.04114604179231531\ \(0\)\
\-\ had\\:\\ 0\\.04080596054205142\ \(0\)\
\-\ in\\:\\ 0\\.04074849279808712\ \(0\)\
\-\ multiple\\:\\ 0\\.04005943501880636\ \(0\)\
\-\ female\\:\\ 0\\.039520885148074336\ \(0\)\
\-\ that\\:\\ 0\\.035541850283392906\ \(0\)\
\-\ be\\:\\ 0\\.03322385649883351\ \(0\)\
\-\ an\\:\\ 0\\.03131856852293992\ \(0\)\
\-\ this\\:\\ 0\\.028142569594127514\ \(0\)\
\-\ and\\:\\ 0\\.016923785465639368\ \(0\)\
\-\ with\\:\\ 0\\.016037189041142784\ \(0\)\
